Our Vision

F2G’s vision is to bring to market safe, convenient, and effective novel antifungal agents to challenge a global unmet need for therapies that are active against resistant infections and also against pathogens which have historically been difficult to treat. F2G’s leading agent, Olorofim, is the first novel anti-fungal treatment developed in the past 20 years and is the only antifungal medication ever to be awarded a Breakthrough Therapy Designation for multiple designations by the FDA. F2G believes that Olorofim, and subsequent agents, will address some of the many challenges which face the treating physician and the patient with invasive fungal infections.

F2G Pharmaceuticals is currently recruiting for an agile, highly motivated Director of Formulation and Process Development to lead and manage product development activities within F2G. *Applicant located in Ireland or UK*

The Director of Formulation and Process Development will be responsible for technical leadership of formulation and process development activities and projects within F2G’s Technical Operations team, which will include CMC strategy, development activities, product registrations and commercialization support within F2G’s pipeline.